featured
Non-Luminal Subtype of MIBC Benefits From Platinum-Based Neoadjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Journal of Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patients With Muscle Invasive Bladder Cancer with Non-luminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy
J Urol 2021 Oct 13;[EPub Ahead of Print], Y Lotan, J de Jong, VYT Liu, TA Bismar, SA Boorjian, HC Huang, E Davicioni, OY Mian, JL Wright, A Necchi, MA Dall'Era, HZ Kaimakliotis, PC Black, EA Gibb, J BoormansFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.